XOMA Corp Business Finance Contracts & Agreements
103 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (11)
- Investment Agreements (2)
- Loan Agreements (14)
- Note Agreements (3)
- Purchase Agreements (13)
- Registration Rights Agreements (1)
- Servicing Agreements (1)
- Share Agreements (20)
- Shareholders Agreements (2)
- Stock Agreements (12)
- Subscription Agreements (1)
- Underwriting Agreements (6)
- Warrant Agreements (16)
- Amendment No. 1 to Royalty Purchase Agreement entered into as of March 4, 2024 by and between Viracta (Filed With SEC on May 9, 2024)
- Payment Interest Purchase Agreement by and between (Filed With SEC on May 9, 2024)
- Sale, Contribution and Servicing Agreement (Filed With SEC on March 8, 2024)
- Loan Agreement dated December 15, 2023, between XRL 1 LLC, the lenders from time to time party thereto and Blue Owl Capital Corporation (Filed With SEC on March 8, 2024)
- Form of Warrant (December 2023) ($50.00 Exercise Price) (Filed With SEC on December 19, 2023)
- Form of Warrant (December 2023) ($42.50 Exercise Price) (Filed With SEC on December 19, 2023)
- Form of Warrant (December 2023) ($35.00 Exercise Price) (Filed With SEC on December 19, 2023)
- Royalty Purchase Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation (Filed With SEC on August 8, 2023)
- Assignment and Assumption Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation (Filed With SEC on August 8, 2023)
- Payment Interest Purchase Agreement, dated March 29, 2023, by and between Aptevo Therapeutics Inc. and XOMA (US) LLC (Filed With SEC on May 9, 2023)
- Amendment and Restatement, dated February 2, 2017, to the Asset Purchase Agreement, dated November 4, 2015, and License Agreement, dated March 23, 2016, between XOMA Corporation... (Filed With SEC on November 3, 2022)
- Commercial Payment Purchase Agreement, dated October 6, 2021, by and among XOMA (US) LLC and Affitech Research AS (Filed With SEC on March 8, 2022)
- Royalty Purchase Agreement, dated July 14, 2021, by and among XOMA (US) LLC and Kuros Royalty Fund (US) LLC (Filed With SEC on November 4, 2021)
- Royalty Purchase Agreement dated March 22, 2021 between XOMA (US) LLC and Viracta Therapeutics, Inc (Filed With SEC on May 6, 2021)
- Deposit Agreement, dated effective as of April 9, 2021, by and among the Company, American Stock Transfer & Trust Company LLC, as depositary, and the holders of the depositary... (Filed With SEC on April 8, 2021)
- Underwriting Agreement, dated as of April 6, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on April 8, 2021)
- Amendment No. 1, dated March 10, 2021, to the Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on March 10, 2021)
- Underwriting Agreement, dated as of December 10, 2020, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on December 11, 2020)
- Amendment No. 3, dated March 31, 2020, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 5, 2020)
- Investment Agreement, dated November 19, 2019 (Filed With SEC on November 20, 2019)
- Royalty Purchase Agreement dated September 26, 2019 between XOMA (US) LLC and Palobiofarma, S.L (Filed With SEC on November 5, 2019)
- Royalty Purchase Agreement dated April 7, 2019, between XOMA (US) LLC and Aronora, Inc (Filed With SEC on August 6, 2019)
- First Amendment, dated March 4, 2019, to the Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley... (Filed With SEC on May 6, 2019)
- Form of Warrant (March 2019 Warrant) (Filed With SEC on May 6, 2019)
- Amendment No. 2, dated January 7, 2019, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2019)
- Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on December 18, 2018)
- Investment Agreement, dated November 6, 2018 (Filed With SEC on November 7, 2018)
- Royalty Purchase Agreement dated September 20, 2018, between XOMA Corporation and Agenus Inc (Filed With SEC on November 7, 2018)
- Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley Bank (Filed With SEC on August 7, 2018)
- Form of Warrant (May 2018 Warrant) (Filed With SEC on August 7, 2018)
- Amendment No.1, dated March 30, 2018 to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 9, 2018)
- Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2018)
- Amendment No. 3, effective January 17, 2017, to the Loan Agreement, effective December 30, 2010, by and among XOMA (US) LLC, Les Laboratoires Servier and Institut de Recherches... (Filed With SEC on March 7, 2018)
- Amendment No. 1, dated December 20, 2016, to Loan and Security Agreement, dated February 27, 2015, by and among XOMA Corporation, XOMA(US) LLC and XOMA Commercial as borrowers and... (Filed With SEC on March 7, 2018)
- Amendment to Secured Note Agreement, executed September 22, 2017, by and between Novartis Vaccines and Diagnostics, Inc. (formerly Chiron Corporation) and XOMA (US) LLC (Filed With SEC on March 7, 2018)
- Common Stock Purchase Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 6, 2017)
- XOMA CORPORATION AMENDED 2015 EMPLOYEE STOCK PURCHASE PLAN (as amended through May 18, 2017) (Filed With SEC on May 24, 2017)
- XOMA CORPORATION Warrant to Purchase Shares of Common Stock (Filed With SEC on May 4, 2016)
- ASSET PURCHASE AGREEMENT by and among AGENUS WEST, LLC and AGENUS INC. (solely with respect to its obligations under Sections4.4, Section 8.3, and Article7) and XOMA CORPORATION... (Filed With SEC on March 9, 2016)
- Loan and Security Agreement, dated February 27, 2015, by and among XOMA Corporation, XOMA(US) LLC and XOMA Commercial as borrowers and Hercules Technology Growth Capital, Inc., as... (Filed With SEC on May 7, 2015)
